0 Bewertungen
ID

20388

Beschreibung

The purpose of the trial is to determine if extended-release dipyridamole + aspirin [Aggrenox, Asasa ntin] is superior to clopidogrel [Plavix], and if telmisartan [Micardis, Gliosartan, Kinzal, Kinzalm ono, Predxal, Pritor, Samertan, Telmisartan] is superior to placebo, in the presence of background antihypertensive therapy, in prevention of a second stroke in patients who have recently suffered a stroke and therefore are at high risk of suffering another one. End of Trial Study Source & Descriptions: https://clinicaltrials.gov/ct2/show/NCT00153062?term=NCT00153062&rank=1

Link

https://clinicaltrials.gov/ct2/show/NCT00153062?term=NCT00153062&rank=1

Stichworte

Versionen (1)
  1. 21.02.17 21.02.17 -
Hochgeladen am

21. Februar 2017

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY 4.0
Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Zurück zu Modell Kommentaren
Itemgroup Kommentare für :

Item Kommentare für :

  • Neueste
  • Älteste
  • Beliebt
  • Neueste
    • Neueste
    • Älteste
    • Beliebt

    Keine Kommentare

    Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

    End of Trial Concomitant Medication ACE Inhibitors PRoFESS - Prevention Regimen For Effectively Avoiding Second Strokes NCT00153062

    Englisch

    End of Trial Concomitant Medication ACE Inhibitors PRoFESS - Prevention Regimen For Effectively Avoiding Second Strokes NCT00153062

    1 Formulare  
    Concomitant Medication
    Beschreibung

    Concomitant Medication

    Alias
    UMLS CUI-1
    C2347852
    1. Since the visit 5, were any of the non-study medications listed below taken?
    Beschreibung

    Medication taken

    Datentyp

    boolean

    Alias
    UMLS CUI [1]
    C1553892
    If yes, please indicate which of the following were being taken:
    Beschreibung

    If yes, please indicate which

    Datentyp

    integer

    Alias
    UMLS CUI [1]
    C1553892
    ACE Inhibitors
    Beschreibung

    ACE Inhibitors

    Alias
    UMLS CUI-1
    C0003015
    2. Since the visit 5, were any ACE inhibitors taken?
    Beschreibung

    ACE Inhibitors currently taken

    Datentyp

    boolean

    Alias
    UMLS CUI [1]
    C0013227
    If Yes, please indicate which, and total daily dose:
    Beschreibung

    Name of ACE Inhibitor and Total Daily Dose

    Datentyp

    text

    Alias
    UMLS CUI [1,1]
    C0003015
    UMLS CUI [1,2]
    C2360065
    UMLS CUI [2,1]
    C0003015
    UMLS CUI [2,2]
    C2348070
    Restricted Concomitant Medication
    Beschreibung

    Restricted Concomitant Medication

    Alias
    UMLS CUI-1
    C2347852
    UMLS CUI-2
    C0233470
    3. Have any restricted medications in the categories defined on the opposite page been taken?
    Beschreibung

    Restricted medication taken

    Datentyp

    boolean

    Alias
    UMLS CUI [1,1]
    C1518384
    UMLS CUI [1,2]
    C0087111
    If yes, please indicate which category
    Beschreibung

    if yes

    Datentyp

    integer

    Alias
    UMLS CUI [1]
    C0683312
    Zum Seitenanfang zurückkehren

    Ähnliche Modelle

    End of Trial Concomitant Medication ACE Inhibitors PRoFESS - Prevention Regimen For Effectively Avoiding Second Strokes NCT00153062

    1 Formulare
    Name
    Typ
    Description | Question | Decode (Coded Value)
    Datentyp
    Alias
    Item Group
    Concomitant Medication
    C2347852 (UMLS CUI-1)
    Medication taken
    Item
    1. Since the visit 5, were any of the non-study medications listed below taken?
    boolean
    C1553892 (UMLS CUI [1])
    Item
    If yes, please indicate which of the following were being taken:
    integer
    C1553892 (UMLS CUI [1])
    If yes, please indicate which
    Code List
    If yes, please indicate which of the following were being taken:
    CL Item
    Parental anticoagulants (Short term use) (1)
    CL Item
    Oral anticoagulants (Short term use) (2)
    CL Item
    Nitrates (oral or topical) (3)
    CL Item
    Estrogen replacement without progesterone (4)
    CL Item
    Estrogen replacement with progesterone (5)
    CL Item
    Digitalis (6)
    CL Item
    Statins (7)
    CL Item
    Fibrates (8)
    CL Item
    Dilitazem/Verapamil (9)
    CL Item
    Other calcium channel blockers (10)
    CL Item
    Alpha-blocker (11)
    CL Item
    Direct vasodilators (12)
    CL Item
    Peripheral sympatholytic (13)
    CL Item
    Central sympatholytic (14)
    CL Item
    Alpha-beta blocker (15)
    CL Item
    Beta-blocker (16)
    CL Item
    Loop-active diuretics (17)
    CL Item
    Diuretics of thiazide type (18)
    CL Item
    Potassium-sparing diuretics (19)
    CL Item
    Insulin (20)
    CL Item
    Oral hypoglycemic agents (21)
    CL Item
    Specific Cox II inhibitors (22)
    Item Group
    ACE Inhibitors
    C0003015 (UMLS CUI-1)
    ACE Inhibitors currently taken
    Item
    2. Since the visit 5, were any ACE inhibitors taken?
    boolean
    C0013227 (UMLS CUI [1])
    Name of ACE Inhibitor and Total Daily Dose
    Item
    If Yes, please indicate which, and total daily dose:
    text
    C0003015 (UMLS CUI [1,1])
    C2360065 (UMLS CUI [1,2])
    C0003015 (UMLS CUI [2,1])
    C2348070 (UMLS CUI [2,2])
    Item Group
    Restricted Concomitant Medication
    C2347852 (UMLS CUI-1)
    C0233470 (UMLS CUI-2)
    Restricted medication taken
    Item
    3. Have any restricted medications in the categories defined on the opposite page been taken?
    boolean
    C1518384 (UMLS CUI [1,1])
    C0087111 (UMLS CUI [1,2])
    Item
    If yes, please indicate which category
    integer
    C0683312 (UMLS CUI [1])
    if yes
    Code List
    If yes, please indicate which category
    CL Item
    1 (1)
    CL Item
    2 (2)
    CL Item
    3 (3)
    CL Item
    4 (4)
    CL Item
    5 (5)
    CL Item
    6 (6)
    CL Item
    7 (7)
    Zum Seitenanfang zurückkehren 

    Hilfe

    Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

    Zum Video